Liver steatosis is positively associated with plasminogen activator inhibitor-1 in apparently healthy individuals with overweight and obesity: A FibroScan-Based Cross-Sectional study

Liver steatosis is positively associated with plasminogen activator inhibitor-1 in apparently healthy individuals with overweight and obesity: A FibroScan-Based Cross-Sectional study

Abstract Background Metabolic dysfunction-associated steatotic liver disease (MASLD) is the most common cause of steatotic liver disease and has major implications on cardiovascular safety. Study aims As the precise role linking MASLD to cardiovascular diseases is still unclear, the present study ai...

Full description

Saved in:
Bibliographic Details
Main Authors: Giuseppe Lisco, Davide Guido, Nicole Cerabino, Martina Di Chito, Rosanna Donvito, Caterina Bonfiglio, Endrit Shahini, Marianna Zappimbulso, Cristiana Randazzo, Domenico Barletta, Dolores Stabile, Anna Ancona, Sergio Coletta, Pasqua Letizia Pesole, Gianluigi Giannelli, Giovanni De Pergola
Format: Article
Language:English
Published: BMC 2025-04-01
Series:Journal of Translational Medicine
Subjects:
Obesity
Overweight
Liver steatosis
Liver fibrosis
Fibroscan
PAI-1
Online Access:https://doi.org/10.1186/s12967-025-06464-9
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1186/s12967-025-06464-9

Similar Items